Skip to main content

Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.

Publication ,  Journal Article
Parsons, JB; Mourad, A; Conlon, BP; Kielian, T; Fowler, VG
Published in: Nat Rev Microbiol
February 2026

Staphylococcus aureus is capable of infecting every organ system in the body and developing resistance to every available antibiotic used to treat it, such as methicillin-resistant S. aureus (commonly referred to as MRSA). This pathogen is characterized by the sudden emergence of virulent new clones and an array of mechanisms to circumvent the immune system and antibiotics. Furthermore, despite the development of new antibiotics and a growing body of high-quality data to inform their use, S. aureus continues to be a leading bacterial cause of death worldwide. In this Review, we provide an overview of the basic research on the complex interplay between S. aureus, the host and antibiotics. We also provide an update on the contemporary clinical studies on the treatment and prevention of S. aureus.

Duke Scholars

Published In

Nat Rev Microbiol

DOI

EISSN

1740-1534

Publication Date

February 2026

Volume

24

Issue

2

Start / End Page

127 / 145

Location

England

Related Subject Headings

  • Staphylococcus aureus
  • Staphylococcal Infections
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Immune Evasion
  • Humans
  • Host-Pathogen Interactions
  • Anti-Bacterial Agents
  • Animals
  • 3107 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Parsons, J. B., Mourad, A., Conlon, B. P., Kielian, T., & Fowler, V. G. (2026). Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nat Rev Microbiol, 24(2), 127–145. https://doi.org/10.1038/s41579-025-01226-2
Parsons, Joshua B., Ahmad Mourad, Brian P. Conlon, Tammy Kielian, and Vance G. Fowler. “Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.Nat Rev Microbiol 24, no. 2 (February 2026): 127–45. https://doi.org/10.1038/s41579-025-01226-2.
Parsons JB, Mourad A, Conlon BP, Kielian T, Fowler VG. Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nat Rev Microbiol. 2026 Feb;24(2):127–45.
Parsons, Joshua B., et al. “Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment.Nat Rev Microbiol, vol. 24, no. 2, Feb. 2026, pp. 127–45. Pubmed, doi:10.1038/s41579-025-01226-2.
Parsons JB, Mourad A, Conlon BP, Kielian T, Fowler VG. Methicillin-resistant and susceptible Staphylococcus aureus: tolerance, immune evasion and treatment. Nat Rev Microbiol. 2026 Feb;24(2):127–145.

Published In

Nat Rev Microbiol

DOI

EISSN

1740-1534

Publication Date

February 2026

Volume

24

Issue

2

Start / End Page

127 / 145

Location

England

Related Subject Headings

  • Staphylococcus aureus
  • Staphylococcal Infections
  • Microbiology
  • Methicillin-Resistant Staphylococcus aureus
  • Immune Evasion
  • Humans
  • Host-Pathogen Interactions
  • Anti-Bacterial Agents
  • Animals
  • 3107 Microbiology